Spinal cord malignant astrocytomas: Clinicopathologic features in 36 cases

Cancer

Volumn 98, Issue 3, 2003, Pages 554-561

  Santi, Mariarita ^a   Mena, Hernando ^b   Wong, Kondi ^b   Koeller, Kelly ^b   Olsen, Cara ^c   Rushing, Elisabeth J ^b,d  

^a CHILDREN'S NATIONAL MEDICAL CENTER   (United States)

^b ARMED FORCES INSTITUTE OF PATHOLOGY   (United States)

^c UNIFORMED SERVICES UNIVERSITY OF THE HEALTH SCIENCES   (United States)

^d U S ARMY   (United States)

Author keywords

Astrocytoma; Glioblastoma multiforme; Prognostic features; Spinal cord

Indexed keywords

PROTEIN P53;

ADULT; AGED; ARTICLE; ASTROCYTOMA; BRAIN METASTASIS; CANCER CHEMOTHERAPY; CANCER GRADING; CANCER LOCALIZATION; CANCER RADIOTHERAPY; CANCER SURGERY; CANCER SURVIVAL; CELL PROLIFERATION; CENTRAL NERVOUS SYSTEM METASTASIS; CLINICAL ARTICLE; CLINICAL FEATURE; FEMALE; GLIOBLASTOMA; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; MALE; NERVE FIBER; PRIORITY JOURNAL; PROGNOSIS; PROTEIN EXPRESSION; SPINAL CORD TUMOR; TUMOR BIOPSY;

ADOLESCENT; ADULT; AGE DISTRIBUTION; AGED; AGED, 80 AND OVER; ANTINEOPLASTIC AGENTS; ASTROCYTOMA; CELL DIVISION; CHILD; CHILD, PRESCHOOL; COMBINED MODALITY THERAPY; FEMALE; HUMANS; IMMUNOENZYME TECHNIQUES; KI-67 ANTIGEN; MALE; MIDDLE AGED; NEOPLASM RECURRENCE, LOCAL; NEOPLASM STAGING; PROGNOSIS; RADIOTHERAPY DOSAGE; SPINAL CORD NEOPLASMS; SURVIVAL RATE; TREATMENT OUTCOME; TUMOR SUPPRESSOR PROTEIN P53;

EID: 0037961257     PISSN: 0008543X     EISSN: None     Source Type: Journal    
DOI: 10.1002/cncr.11514     Document Type: Article

References (45)

1. Salcman M. Glioblastoma and malignant astrocytoma. In: Kaye AH, Laws ER, editors. Brain tumors. New York: Churchill-Livingstone, 1995.
2. Kim MS, Chung CK, Choe G, Kim IH, Kim HJ. Intramedullary spinal cord astrocytoma in adults: postoperative outcome. J Neurosurg. 2001;52:85-94.
3. Kleihues P, Burger PC, Collins VP, Newcomb EW, Ohgaki H, Cavenee WK. Glioblastoma. In: Kleihues P, Cavenee WK. Pathology and genetics of tumors of the nervous system, World Health Organization classification of tumors. Lyon: International Agency for Research on Cancer, 2000:29-39.
4. Reimer R, Onofrio BM. Astrocytomas of the spinal cord in children and adolescents. J Neurosurg. 1985;63:669-675.
5. Sandler HM, Papadopoulos SM, Thornton AF Jr., Ross DA. Spinal cord astrocytomas: results of therapy. Neurosurgery. 1992;30:490-493.
6. Constantini S, Miller DC, Allen JC, Rorke LB, Freed D, Epstein FJ. Radical excision of intramedullary spinal cord tumors: surgical morbidity and long-term follow-up evaluation in 164 children and young adults. J Neurosurg (Spine). 2000;93:183-193.
7. DeSousa AL, Kalsbeck JE, Mealey T Jr., Campbell RL, Hockey A. Intraspinal tumors in children. A review of 81 cases. J Neurosurg. 1979;51:437-445.
8. Henson JW. Spinal cord gliomas. Curr Opin Neurol. 2001;14:679-682.
9. Henson JW, Thornton AF, Louis DN. Spinal cord astrocytoma: response to PCV chemotherapy. Neurology. 2000;54:518-520.
10. Merchant TE, Nguygen D, Thompson SJ, Reardon DA, Kun LE, Sanford RA. High-grade pediatric spinal cord tumors. Pediatr Neurosurg. 1999;30:1-5.
11. Ciappetta P, Salvati M, Capoccia G, Artico M, Raco A, Fortuna A. Spinal gliobastomas: report of seven cases and review of the literature. Neurosurgery. 1991;28:302-306.
12. Houten JK, Cooper PR. Spinal cord astrocytomas: presentation, management and outcome. J Neurooncol. 2000;47:219-224.
13. Lantos PL, Vandenberg SR, Kleihues P. Tumours of the nervous system. In: Graham PI, Lantos PL, editors. Greenfield's neuropathology. London: Arnold, 1997:583-620.
14. Miller DC. Surgical pathology of intramedullary spinal cord neoplasms. J Neurooncol. 2000;47:189-194.
15. Isaacson SR. Radiation therapy and the management of intramedullary spinal cord tumors. J Neurooncol. 2000;47:231-238.
16. Coakley KJ, Huston J 3rd, Scheithauer BW, Forbes G, Kelly PJ. Pilocytic astrocytomas: well-demarcated magnetic resonance appearance despite frequent infiltration histologically. Mayo Clin Proc. 1995;70:747-751.
17. Minehan KJ, Shaw EG, Scheithauer BW, Davis DL, Onofrio BM. Spinal cord astrocytoma: pathological and treatment considerations. J Neurosurg. 1995;83:590-595.
18. Ng HK, Leung CH, Boet R, Poon WS. Spinal cord pilocytic astrocytoma with cranial meningeal metastases. J Clin Neurosci. 2001;8:374-377.
19. Rossitch E Jr., Zeidman SM, Burger PC, et al. Clinical and pathological analysis of spinal cord astrocytomas in children. Neurosurgery. 1990;27:193-196.
20. Steinbok P. Spinal cord astrocytomas: long-term results comparing treatments in children. Childs Nerv Syst. 1998;14:1.
21. Allen JC, Aviner S, Yates AJ, et al. Treatment of high-grade spinal cord astrocytoma of childhood with "8-in1" chemotherapy and radiotherapy: a pilot study of CCG-945. J Neurosurg. 1998;88:215-220.
22. Andrews AA, Enriques L, Renaudin J, Tomiyasu U. Spinal intramedullary glioblastoma with intracranial seeding. Report of a case. Arch Neurol. 1978;35:244-245.
23. Cohen AR, Wisoff JH, Allen JC, Epstein F. Malignant astrocytoma of the spinal cord. J Neurosurg. 1989;70:50-54.
24. Grisold W, Pernetzky G, Jellinger K. Giant-cell glioblastoma of the thoracic cord. Acta Neurochir (Wien). 1981;58:121-126.
25. Kalyan-Raman UP, Cancilla PA, Case MJ. Solitary, primary malignant astrocytoma of the spinal leptomeninges. J Neuropathol Exp Neurol. 1983;42:517-521.
26. Kendrick FD, Bonnin JM, Garcia JH. Metastases of a spinal glioblastoma multiforme into an intracranial arachnoid cyst. Neurosurgery. 1987;20:780-783.
27. Kopelson G, Lingood RM. Intramedullary spinal cord astrocytoma versus glioblastoma multiforme. The prognostic importance of histologic grade. Cancer. 1982;50:732-735.
28. Kulkarni AV, Armstrong DC, Drake JM. MR characteristics of malignant spinal cord astrocytomas in children. Can J Neurol Sci. 1999;26:290-293.
29. Kyoshima K, Ito K, Tanabe A, et al. Malignant astrocytoma of the conus medullaris treated by spinal cordectomy. J Clin Neurosci. 2002;9 211-216.
30. Hassard TH. Understanding biostatistics. St. Louis, MO: Mosby Year Book, 1991:273.
31. Epstein FJ, Farmer JP, Freed D. Adult intramedullary astrocytomas of the spinal cord. J Neurosurg. 1992;77:355-359.
32. Kirla R, Salminen E, Huhtala S, et al. Prognostic value of the expression of tumor suppressor genes p53, p21, p16 and prb, and Ki-67 labelling in high grade astrocytomas treated with radiotherapy. J Neurooncol. 2000;46:71-80.
33. Kleihues P, Davis RL, Coons SW, Burger PC. Anaplastic astrocytoma. In: Kleihues P, Cavenee WK, editors. Pathology and genetics of tumors of the nervous system, World Health Organization classification of tumors. Lyon: International Agency for Research on Cancer, 2000:27-28.
34. Montine TJ, Vandersteenhoven JJ, Aguzzi A, et al. Prognostic significance of Ki-67 proliferation index in supratentorial fibrillary astrocytic neoplasms. Neurosurgery. 1994;34:674-678.
35. Bouvier-Labit C, Chinot O, Ochi C, Gambarelli D, Dufour H, Figarella-Branger D. Prognostic significance of Ki67, p53 and epidermal growth factor receptor immunostaining in human glioblastomas. Neuropathol Appl Neurobiol. 1998;24:381-388.
36. Iwata K, Nakagawa H, Hashizume Y. Significance of MIB-1, PCNA indices, and p53 protein over-expression in intramedullary tumors of the spinal cord. Noshuyo Byori. 1996;13:73-78.
37. Sarkar C, Ralte AM, Sharma MC, Mehta VS. Recurrent astrocytic tumours - a study of p53 immunoreactivity and malignant progression. Br J Neurosurg. 2002;16:335-342.
38. Strik HM, Effenberger O, Schafer O, Risch U, Wickboldt J, Meyermann R. A case of spinal glioblastoma multiforme: immunohistochemical study and review of the literature. J Neurooncol. 2000;50:239-243.
39. Mortara R, Parker JC Jr., Brooks WH. Glioblastoma multiforme of the spinal cord. Surg Neurol. 1974;2:115-119.
40. Herpers MJ, Freling G, Beuls EA. Pleomorphic xanthoastrocytoma in the spinal cord. Case report. J Neurosurg. 1994;80:564-569.
41. Kopelson G, Linggood RM, Kleinman GM, Doucette J, Wang CC. Management of intramedullary spinal cord tumors. Radiology. 1980;135:473-479.
42. Goh KY, Velasquez L, Epstein FJ. Pediatric intramedullary spinal cord tumors: is surgery alone enough? Pediatr Neurosurg. 1997;27:34-39.
43. Balmaceda C. Chemotherapy for intramedullary spinal cord tumors. J Neurooncol. 2000;47:293-307.
44. Jyothirmani R, Madhavan J, Nair MK, Rajan B. Conservative surgery and radiotherapy in the treatment of spinal cord astrocytoma. J Neurooncol. 1997;33:205-211.
45. McLaughlin MP, Buatti JM, Marcus RB Jr., Maria BL, Mickle PJ, Kedar A. Outcome after radiotherapy of primary spinal cord glial tumors. Radiat Oncol Invest. 1998;6:276-280.